The fact that chemical carcinogenesis involves single, isolated, essentially irreversible molecular events as discrete steps, several of which must occur in a row to finally culminate in the development of a malignancy, rather suggests that an absolute threshold for chemical carcinogens may not exist. However, practical thresholds may exist due to saturable pathways involved in the metabolic processing, especially in the metabolic inactivation, of such compounds. An important example for such a pathway is the enzymatic hydrolysis of epoxides via epoxide hydrolases, a group of enzymes for which the catalytic mechanism has recently been established. These enzymes convert their substrates via the intermediate formation of a covalent enzyme-substrate complex. Interestingly, the formation of the intermediate proceeds faster by orders of magnitude than the subsequent hydrolysis, ie, the formation of the terminal product. Under normal circumstances, this does not pose a problem, since the microsomal epoxide hydrolase (mEH), the epoxide hydrolases with the best documented importance in the metabolism of carcinogens, is highly abundant in the liver, the organ with the highest capacity to metabolically generate epoxides. Computer simulation provides evidence that the high amount of mEH enzyme is favorable for the control of the steady-state level of a substrate epoxide and can keep it extremely low. However, once the mEH is titrated out under conditions of extraordinarily high epoxide concentration, the epoxide steady-state level steeply rises, leading to a sudden burst of the genotoxic effect of the noxious agent. This prediction of the computer simulation is nicely supported by experimental work. V79 Chinese hamster cells that we have genetically engineered to express human mEH at about the same level as that observed in human liver are completely protected from any measurable genotoxic effect of the model compound styrene oxide (STO) up to a dose of 100 &mu;M in the cell culture medium (toxicokinetic threshold). In V79 cells that do not express mEH, STO leads to the formation of DNA strand breaks in a dose-dependent manner with no toxicokinetic threshold observable. Above 100 &mu;M, the genotoxic effect of STO in the mEH-expressing cell line parallels the one in the parental cell line. Thus, the saturable protection from STO-induced strand breaks by mEH represents a typical example of a practical threshold. However, it must be pointed out that even in the presence of protective amounts of mEH, a minute but definite level of STO is present that does not contribute sufficiently to the strand break formation to overcome the background noise of the detection procedure. As pointed out above, absolute thresholds probably do not exist in chemical carcinogenesis. Keywords. Epoxide hydrolase; & a l p h a ; / & b e t a ; hydrolase fold; ester intermediate; epoxy compounds metabolism; V79 Chinese hamster lung fibroblasts; DNA damage; genotoxicity
INTRODUCTION
It is often stated that genotoxic carcinogens do not show a threshold for their effect (11, 12, 15) . This is based on the view of genotoxic effects as stochastic, irreversible events, in contrast to, eg, pharmacologic and toxicological effects of a drug that are reversible, in most cases. Figure 1 illustrates the principal difference between these 2 phenomena under the simplifying generalization that many pharmacologic effects are evoked by concentration-dependent receptor interactions, and the genotoxic effect is based on a covalent, essentially nonreversible modification of the DNA. Receptor-mediated effects most often require a minimum percentage of the respective receptor molecules to be occupied, the classical setting for a threshold, whereas the DNA alteration eventually giving rise to a discrete step in cancer development is the consequence of a single hit. Thus, the chance for tumor induction decreases linearly with the dose of the genotoxic carcinogen, whereas the likelihood for a pharmacologic effect decreases steeply beyond the threshold dose and rapidly approaches 0. From this point of view, there is indeed no indication for a threshold in chemical carcinogenesis (the case of nongenotoxic carcinogens for which threshold effects have been documented is not the subject of this paper). However, this simple view neglects the kinetic properties of genotoxic agents, the concentrations of which are often tightly controlled by drug-metabolizing enzymes.
XENOBIOTIC-METABOLIZING ENZYMES CONTROL THE GENOTOXICITY OF FOREIGN COMPOUNDS
Although there are a fair number of direct-acting mutagens/carcinogens, most genotoxic agents require metabolic activation in order to become sufficiently reactive to chemically interact with the DNA. In order to allow elimination of initially lipophilic compounds via the aqueous excretion systems of the mammalian body, a huge network of xenobiotic-metabolizing enzymes that take care of these compounds has evolved. During biotransformation by these enzymes, some compounds are &dquo;accidentally&dquo; activated to genotoxic metabolites. Figure I FIGURE 1.-Threshold or no threshold? A) A typical pharmacologic drug (ligand) occupies a receptor reversibly in an equilibrium-driven process. Below a certain concentration of the drug, the percentage of occupied receptors, such as, eg, ligand-dependent ion channels in the cell membrane, does not evoke the drug-specific effect, which only becomes apparent after rising above the threshold concentration. B) A genotoxic carcinogen (modifying agent) binds with a concentration-dependent probability, yet in a stochastic event, covalently to the DNA (target) of a cell. This process is, by its nature, essentially irreversible in the sense that it is not equilibrium driven. Since a single hit can be sufficient to start the cascade of events finally leading to carcinogenesis, there is no apparent threshold for this effect. lipophilic and-in the present case-genotoxic compound. In the so-called phase 1 of drug metabolism, the molecule is functionalized either by introduction or liberation of a functional group that can be used as a kind of handle in phase 2 of drug metabolism to conjugate the molecule, usually with a hydrophilic, negatively charged, endogenous chemical building block. The resulting terminal metabolite is generally nonreactive, nontoxic, and FIGURE 2.-Carcinogen metabolism. This scheme is an adaptation of the well-known phase model of drug metabolism for the carcinogen metabolism. As a general rule, carcinogens are chemically activated during phase I metabolism (therefore the designation procarcinogen) and inactivated during phase II metabolism. However, for both rules there are a number of exceptions. The table above gives a list of the enzyme families with implication in the metabolism of carcinogenic compounds. Although only few isoenzymes are known in some of these families, others may contain more than 100 individual enzymes. highly water soluble, and thus easily excreted. The functionalized intermediate arising from phase 1 metabolism, however, is chemically more or less reactive. If the functional group that has been introduced is electrophilic in nature, as is, for instance, the case with epoxides (see Figure 3 ), it has a tendency to react with electron-rich moieties in the DNA and give rise to the formation of DNA adducts, DNA strand breaks, or both. One example for a compound that is activated to a genotoxic intermediate in the human body is styrene (Figure 4 ), a compound produced in thousands of tons per year to satisfy the demand of the plastics industries. Luckily, the genotoxic intermediate, an epoxide, is itself rapidly inactivated by the microsomal epoxide hydrolase (mEH; EC 3.3.2.3), an important enzyme that protects the body from the hazardous effects of many exogenous or endogenous epoxides (13) . The metabolic capacity of mEH determines a practical threshold for the genotoxicity of compounds that are inactivated by this enzyme.
THE MICROSOMAL EPOXIDE HYDROLASE-FAST DETOXIFICATION DESPITE LOW TURNOVER NUMBER

Mechanistic Background
The very broad substrate specificity of mEH perfectly suits its central role in the detoxification of genotoxic epoxides. On the other hand, the enzyme displays a comparatively low turnover number with most of its substrates, usually smaller than 1 s-1 (16) . This seems to be partly compensated by the fact that the mEH concentration in the human liver, the prominent organ for intermediate epoxide formation in the body, is very high ( 10-50 ~LM, simplified, taking the whole organ as the &dquo;sol-vent&dquo;) but still compromises its role as a rapid detoxifier.
Recent analyses have led to a detailed understanding FIGURE 3.-Genotoxic effect of epoxides. Epoxides, ie, 3-membered heterocycles with an oxygen as the hetero atom, are reactive compounds due to the strain arising from the unfavorable bond angles and the difference in electronegativity of the binding partners in the ring. The ring carbon atoms represent electrophilic centers that can chemically react with electron-rich partners, such as the exocyclic amino groups of DNA bases or the N7 position of purine bases. The latter modification destabilizes the bond between base and sugar in the DNA and thus leads to apurinic sites that can be transformed into single strand breaks under alkaline conditions. The substitution pattern (R,-R4) of the epoxide modulates its reactivity in that asymmetric substitution increases the reactivity at one of the electrophilic centers, whereas symmetric substitution usually has a stabilizing effect. Epoxide hydrolases are enzymes specialized in the hydrolysis of the epoxide ring. This reaction eliminates the electrophilic reactivity and thus the genotoxicity of the epoxide. The resulting metabolites can usually be excreted either directly or after conjugation to glucuronic acid or sulfate. It should be mentioned, however, that some specific diols formed during the metabolism of polycyclic aromatic hydrocarbons can be further metabolized to the corresponding diol epoxides, a class of potent ultimate carcinogens. of the enzymatic mechanism, by which mEH and the related soluble epoxide hydrolase hydrolyze their substrates (1-3, 5, 7-10, 17, 18) . These enzymes belong to the large structural family of &OElig;/~ hydrolase fold enzymes (14) . These hydrolytic enzymes harbor a so-called catalytic triad. In the first step of the enzymatic reaction ( Figure 5 ), the catalytic nucleophile, which is an aspartic acid residue in the case of the epoxide hydrolases, attacks the substrate to form an enzyme-substrate ester intermediate. This is subsequently hydrolyzed by an activated water molecule. Water activation is achieved by proton abstraction through a charge-relay system composed of a histidine residue that is hydrogen bonded to an acidic residue, either glutamic or aspartic acid. Experimental evidence clearly shows that in the case of enzymatic epoxide hydrolysis, the first step of the reaction proceeds significantly faster than the second step, which therefore becomes rate limiting. Armstrong and colleagues (18) have calculated the rate constant of step 1 to be 3 orders of magnitude higher than the rate constant for step 2 with glycidyl-4-nitrobenzoate as the substrate. According to our own work, similar reaction kinetics exist for the turnover of styrene oxide and 9,10-epoxystearic acid (2) .
What conclusions can be drawn from this new insight in the enzymatic mechanism of mEH? Certainly, the most important point is to realize that the rate of product formation does not adequately mirror the detoxification ef- -Metabolism of styrene in the human body. The major route of styrene metabolism in man is represented. The predominant excretion products are mandelic acid and phenyl glyoxylic acid. The first step in the metabolism is epoxidation in the 7,8-position, ie, the vinyl group, to the 7,8-epoxide. This reaction is catalyzed by a number of different cytochrome P450-dependent monooxygenases. The epoxide can be readily hydrolyzed by epoxide hydrolases. Subsequently, the resulting glycol is further oxidized by the sequential action of an alcohol dehydrogenase (ADH) and an aldehyde dehydrogenase to mandelic acid, which is either directly excreted or metabolized again by an ADH to phenyl glyoxylic acid. The indices of the individual amino acid residues designate their respective positions in the mEH amino acid sequence. FIGURE 6.-Computer simulation of the reaction kinetics of enzymatic epoxide hydrolysis. A) Time course of the reaction after a single application of epoxide (from t = 0 to 1 second). Parameters for the simulation were the following: enzyme concentration = 50 p,M; substrate concentration at the beginning = 5 pLM: kp = 500 pLM; k, (rate constant for the formation of the ester intermediate) = 1000 s-'; k, (rate ficiency of the enzyme. Because step 1 is so much faster than step 2 of the enzymatic reaction, the ester intermediate will accumulate at the cost of the substrate, ie, the free epoxide. Thus, the enzyme works like a molecular sponge in that it first consumes much more epoxide than diol, the terminal reaction product is formed. As long as the enzyme is in excess over its substrate, which can be taken as a realistic setting under physiological conditions, the epoxide is eliminated much faster than the diol is formed. This theoretical consideration can be tested in a first step by computer simulation (Figure 6 ). As anticipated, the in silico analysis reveals a much faster decrease in epoxide concentration compared with the increase in diol formation ( Figure 6A ). Thus, the effective dose of the genotoxic agent, as represented by the area under the time-concentration curve, is actually much smaller than the calculation from the formed diol predicts ( Figure 6B ). Also very important is the finding that there is a direct proportional relationship between epoxide steady-state concentration and epoxide hydrolase concentration, also under conditions well below substrate saturation ( Figure  6C ).
Experimental Proof
A convenient way to test the importance of a given detoxifying enzyme in the control of a genotoxic agent is its recombinant expression in a suitable indicator cell line and the subsequent analysis of the susceptibility of the recombinant cell line, as well as the parental cell line, toward the genotoxic effect of the compound in question.
(constant for the hydrolysis of the ester intermediate) = 1 s-'. The most important observation from this simulation is that the free substrate disappears rapidly, while the ester intermediate accumulates at the same time. From this reservoir, the product is formed at a much slower rate because of the large difference between k, and k2. B) Comparison between the authentic concentration of the substrate over time and the substrate concentration calculated from the appearance of the terminal product (the usual analytical approach) from the data shown in (A). It is apparent that the authentic substrate calculation is orders of magnitude lower than that obtained by calculation from the formation of the terminal product. Since the area under the curve is proportional to the biological effect of the compound in the given system, the conventional approach to determine the substrate concentration from product formation heavily overestimates the substrate concentration and underestimates the protective effect of the enzymatic detoxification. C) Simulation of the influence of mEH concentration on the substrate epoxide under steady state conditions. Conditions were as described under (A), with the exception that the substrate was continuously supplied at a rate of I plum s and the half-life of the substrate due to spontaneous hydrolysis was set to 1 s (this is about the shortest half-life reported for epoxides to date; the shorter the half-life, the lower the contribution of enzymatic hydrolysis). Despite these stringent conditions, the epoxide hydrolase still drastically reduces the steady state open circles) and derivatives thereof stably expressing mEH at a rate comparable to that in human liver (closed circles) were exposed to styrene 7,8-oxide at different concentrations for 1 hour, and the rate of DNA strand break formation was determined by the alkaline elution technique (6) . Each circle represents the mean of 4 separate determinations, and the error bars represent the standard deviation. The data clearly document a protective effect by mEH expression up to at least a styrene oxide concentration of 100 ~,M. The graph is the representative example of 3 independent experiments.
We have used V79 Chinese hamster fibroblast cells (4) as the indicator cell line and tested the influence of recombinant mEH expression on the styrene oxide-induced DNA strand breaks, as measured by the alkaline elution technique (6; Figure 7 ). The results of these experiments clearly show that the expression of mEH protects V79 cells from styrene oxide-induced DNA strand break formation up to a concentration of at least 100 RM. Above this, a steep rise in the genotoxic effect of the agent is noted. In contrast, the parental cell line that is devoid of any mEH expression shows a monophasic, dose-dependent increase in DNA strand breaks without the initial lag phase observed with the mEH-expressing cells. Thus, mEH expression introduces a threshold for the susceptibility of V79 cells to styrene oxide genotoxicity.
The above-described enzymatic mechanism is 1 important factor contributing to the high clearance of styrene oxide by mEH; yet it may not be sufficient as a stand-alone explanation for the observed threshold. In the experiment shown in Figure 7 , the threshold concentration of 100 )JbM equals a total amount of 500 nmol styrene oxide in the entire culture dish (cells plus medium). The total amount of mEH in one dish, however, is only about FIGURE 8.-Immunofluorescence analysis of the mEH-expressing V79 fibroblasts. The recombinant cells were permeabilized, and the localization of the mEH in the ER was visualized by immunodetection with an mEH-specific antibody in combination with a second fluorescein isothiocyanate-conjugated antibody. The ER is represented as a dense network tightly surrounding the nucleus of the cell. 500 pmol, although the mEH concentration within a single cell is similar to that of the epoxide, namely about 50 j..LM. Since in this setting there is a large substrate excess in terms of numbers of substrate molecules in the entire culture dish, but in the cell there are approximately equimolar concentrations of substrate and enzyme at the practical threshold level, this threshold may be dominated by the cellular concentrations of the partners. This implies that the replenishment of substrate at the site of enzyme may not be substantially faster than the regeneration of the free enzyme. As the immunofluorescence analysis of the recombinant cells shows (Figure 8 ), the mEH is localized in the endoplasmic reticulum (ER) that surrounds the cell nucleus, the target structure of genotoxic agents. This potentially leads to a filter effect for many lipophilic epoxides, such as the styrene oxide, before they can enter the cell nucleus. To reach the nucleus, they have to travel along the ER, where they meet mEH. Therefore, the mEH may turn the ER into a barrier that is hard for epoxides to overcome, which eventually leads to a large difference in epoxide concentration between the 2 sites separated by this barrier. Once the capacity of this barrier is exhausted, however, the genotoxic effect of the epoxide becomes apparent.
The detoxification of styrene oxide by mEH represents an illustrative example on how practical thresholds in chemical carcinogenesis are determined by the metabolic fate of genotoxic carcinogens. A number of factors, such as the enzymatic mechanism and the subcellular compartmentalization of the protective enzyme or enzymes, synergize in the protection of the cells against these challenges. Likewise, the kinetics of processes in the activation of carcinogens may lead to nonlinearity in the doseresponse curve of such compounds. These aspects should be considered in the discussion about the existence of practical thresholds in carcinogenesis.
